Targeting impaired antimicrobial immunity in the brain for the treatment of Alzheimer's disease
Alterations in energy metabolism in cardiovascular diseases often involve systemic pathophysiological changes across multiple systems, while the key energy metabolic targets (AMPK, SIRT) exhibit functional variances in different tissues, suggesting the need for in-depth mechanistic exploration using tissue-specific animal models and expanding clinical research in the future
Seim et al., 1985)
Likewise, the suppressor oncogene p53 is capable of suppressing the activity of the IGF-1R promoter as well as lowering the endogenous levels of IGF-1R mRNA (Werner et al, 2000)
Additionally, benefits like lowering blood pressure, improving lipid disorders, improving fatty liver disease, reducing your risk of heart disease and kidney disease, and delaying the progression of diabetes-related nephropathy, have been documented
Saikosaponin A triggers cell ferroptosis in hepatocellular carcinoma by inducing endoplasmic reticulum stress-stimulated ATF3 expression